Published in Rheumatology (Oxford) on June 01, 2004
The expanding family of interleukin-1 cytokines and their role in destructive inflammatory disorders. Clin Exp Immunol (2007) 2.22
Mast cells contribute to initiation of autoantibody-mediated arthritis via IL-1. Proc Natl Acad Sci U S A (2007) 1.84
High mobility group box protein 1 in complex with lipopolysaccharide or IL-1 promotes an increased inflammatory phenotype in synovial fibroblasts. Arthritis Res Ther (2011) 1.27
CXCL16-mediated cell recruitment to rheumatoid arthritis synovial tissue and murine lymph nodes is dependent upon the MAPK pathway. Arthritis Rheum (2006) 1.13
Dual functionality of interleukin-1 family cytokines: implications for anti-interleukin-1 therapy. Br J Pharmacol (2009) 1.08
Measurement of the serum leptin level could assist disease activity monitoring in rheumatoid arthritis. Rheumatol Int (2006) 1.06
Advances in research on animal models of rheumatoid arthritis. Clin Rheumatol (2012) 1.06
Tyrosine kinases as targets for the treatment of rheumatoid arthritis. Nat Rev Rheumatol (2009) 1.01
Pregnancy in patients with rheumatic disease: anti-inflammatory cytokines increase in pregnancy and decrease post partum. Ann Rheum Dis (2004) 1.00
T Cell Migration in Rheumatoid Arthritis. Front Immunol (2015) 0.98
Taurine chloramine differentially inhibits matrix metalloproteinase 1 and 13 synthesis in interleukin-1beta stimulated fibroblast-like synoviocytes. Arthritis Res Ther (2007) 0.92
Regulation of RANKL by biomechanical loading in fibrochondrocytes of meniscus. J Biomech (2005) 0.91
Norisoboldine alleviates joint destruction in rats with adjuvant-induced arthritis by reducing RANKL, IL-6, PGE(2), and MMP-13 expression. Acta Pharmacol Sin (2013) 0.90
Gene therapy for arthritis. Mod Rheumatol (2008) 0.89
Synergy between adiponectin and interleukin-1β on the expression of interleukin-6, interleukin-8, and cyclooxygenase-2 in fibroblast-like synoviocytes. Exp Mol Med (2012) 0.88
The potential for caspases in drug discovery. Curr Opin Drug Discov Devel (2010) 0.86
Interleukin-10 regulates the inflammasome-driven augmentation of inflammatory arthritis and joint destruction. Arthritis Res Ther (2014) 0.86
Arthritis of the large joints - in particular, the knee - at first presentation is predictive for a high level of radiological destruction of the small joints in rheumatoid arthritis. Ann Rheum Dis (2006) 0.85
Prophylactic and therapeutic treatment with a synthetic analogue of a parasitic worm product prevents experimental arthritis and inhibits IL-1β production via NRF2-mediated counter-regulation of the inflammasome. J Autoimmun (2015) 0.84
Messenger RNA delivery of a cartilage-anabolic transcription factor as a disease-modifying strategy for osteoarthritis treatment. Sci Rep (2016) 0.81
The role of nucleotides and purinergic signaling in apoptotic cell clearance - implications for chronic inflammatory diseases. Front Immunol (2014) 0.81
Interleukin-1 signaling pathway as a therapeutic target in transthyretin amyloidosis. Amyloid (2014) 0.81
Changes in surface topologies of chondrocytes subjected to mechanical forces: an AFM analysis. J Struct Biol (2008) 0.80
Effects of interleukin-1β and tumor necrosis factor-α on macrophage inflammatory protein-3α production in synovial fibroblast-like cells from human temporomandibular joints. J Oral Pathol Med (2013) 0.80
Platelet-rich plasma protects rat chondrocytes from interleukin-1β-induced apoptosis. Mol Med Rep (2016) 0.79
Psychological stress alters the ultrastructure and increases IL-1β and TNF-α in mandibular condylar cartilage. Braz J Med Biol Res (2012) 0.79
CD146(+) mesenchymal stem cells display greater therapeutic potential than CD146(-) cells for treating collagen-induced arthritis in mice. Stem Cell Res Ther (2016) 0.79
Upregulation of tumor necrosis factor receptor-associated factor 6 correlated with synovitis severity in rheumatoid arthritis. Arthritis Res Ther (2012) 0.78
Biomechanical strain regulates TNFR2 but not TNFR1 in TMJ cells. J Biomech (2006) 0.78
Small Molecule Active Site Directed Tools for Studying Human Caspases. Chem Rev (2015) 0.77
Interleukin-1β induces fibroblast growth factor 2 expression and subsequently promotes endothelial progenitor cell angiogenesis in chondrocytes. Clin Sci (Lond) (2016) 0.76
Mactinin, a fragment of cytoskeletal alpha-actinin, is a novel inducer of heat shock protein (Hsp)-90 mediated monocyte activation. BMC Cell Biol (2009) 0.76
Arthritis and suicide attempts: findings from a large nationally representative Canadian survey. Rheumatol Int (2016) 0.76
Cytokine gene polymorphisms associate with microbiogical agents in periodontal disease: our experience. Int J Med Sci (2014) 0.75
Interleukin-1 as a mediator of fatigue in disease: a narrative review. J Neuroinflammation (2017) 0.75
Aryl hydrocarbon receptor antagonism and its role in rheumatoid arthritis. J Exp Pharmacol (2015) 0.75
IL-1RA gene-transfected bone marrow-derived mesenchymal stem cells in APA microcapsules could alleviate rheumatoid arthritis. Int J Clin Exp Med (2015) 0.75
Acacetin inhibits expression of matrix metalloproteinases via a MAPK-dependent mechanism in fibroblast-like synoviocytes. J Cell Mol Med (2015) 0.75
Phosphodiesterase 4B negatively regulates endotoxin-activated interleukin-1 receptor antagonist responses in macrophages. Sci Rep (2017) 0.75
A comparison of Illumina and Ion Torrent sequencing platforms in the context of differential gene expression. BMC Genomics (2017) 0.75
Mechanism of action of superoxide dismutase from pulse radiolysis and electron paramagnetic resonance. Evidence that only half the active sites function in catalysis. Biochem J (1974) 2.82
Reduction and inactivation of superoxide dismutase by hydrogen peroxide. Biochem J (1974) 1.92
Studies of the metal sites of copper proteins. Symmetry of copper in bovine superoxide dismutase and its functional significance. Biochemistry (1972) 1.54
Room-temperature magnetic properties of oxy- and carbonmonoxyhemoglobin. Proc Natl Acad Sci U S A (1978) 1.51
Properties of the apoprotein and role of copper and zinc in protein conformation and enzyme activity of bovine superoxide dismutase. Biochemistry (1972) 1.44
Primary follicular and marginal-zone lymphoma of the breast: clinical features, prognostic factors and outcome: a study by the International Extranodal Lymphoma Study Group. Ann Oncol (2009) 1.37
Assays for superoxide dismutase. Methods Biochem Anal (1987) 1.32
Excess of nonceruloplasmin serum copper in AD correlates with MMSE, CSF [beta]-amyloid, and h-tau. Neurology (2006) 1.31
The binding of copper ions to copper-free bovine superoxide dismutase. Copper distribution in protein samples recombined with less than stoicheiometric copper ion/protein ratios. Biochem J (1977) 1.28
Structure to function relationships in ceruloplasmin: a 'moonlighting' protein. Cell Mol Life Sci (2002) 1.25
Indirect evidence for the production of superoxide anion radicals by pig kidney diamine oxidase. Biochim Biophys Acta (1970) 1.22
Double-blind, placebo-controlled multicenter trial using chimeric monoclonal anti-CD4 antibody, cM-T412, in rheumatoid arthritis patients receiving concomitant methotrexate. Arthritis Rheum (1995) 1.18
Synthesis of either Fe- or Mn-superoxide dismutase with an apparently identical protein moiety by an anaerobic bacterium dependent on the metal supplied. J Biol Chem (1982) 1.16
Erythrocuprein and singlet oxygen. FEBS Lett (1972) 1.16
Re-examination of the reaction of diethyldithiocarbamate with the copper of superoxide dismutase. J Biol Chem (1981) 1.15
Joint practice guidelines for radionuclide lymphoscintigraphy for sentinel node localization in oral/oropharyngeal squamous cell carcinoma. Ann Surg Oncol (2009) 1.14
Human Papilloma Virus (HPV) in head and neck region: review of literature. Acta Otorhinolaryngol Ital (2009) 1.05
Incidence and risk factors for progressive multifocal leukoencephalopathy among patients with selected rheumatic diseases. Arthritis Care Res (Hoboken) (2012) 1.05
Is there a role for sentinel node biopsy in early N0 tongue tumors? Surgery (2000) 1.04
pH dependece of the nuclear magnetic relaxation rate of solvent water protons in solutions of bovine superoxide dismutase. Biochim Biophys Acta (1974) 1.03
Role of prophylactic central neck dissection in cN0 papillary thyroid cancer. Acta Otorhinolaryngol Ital (2009) 1.02
Primary structure from amino acid and cDNA sequences of two Cu,Zn superoxide dismutase variants from Xenopus laevis. Arch Biochem Biophys (1989) 0.99
Studies of the metal sites of copper proteins. Ligands of copper in hemocuprein. Biochemistry (1971) 0.98
Lymphatic mapping to tailor selective lymphadenectomy in cN0 tongue carcinoma: beyond the sentinel node concept. Eur J Nucl Med Mol Imaging (2006) 0.97
Intracellular localization of superoxide dismutase and its relation to the distribution and mechanism of hydrogen peroxide-producting enzymes. Biochim Biophys Acta (1973) 0.95
Age-related changes in human ceruloplasmin. Evidence for oxidative modifications. J Biol Chem (1993) 0.94
Papillary carcinoma in thyroglossal duct remnants: presentation of four cases and decision procedure for prophylactic thyroid gland dissection. Oncol Rep (2000) 0.94
The binding of copper ions to copper-free bovine superoxide dismutase. Properties of the protein recombined with increasing amounts of copper ions. Biochem J (1977) 0.94
Cobalt bovine superoxide dismutase. Reactivity of the cobalt chromophore in the copper-containing and in the copper-free enzyme. Eur J Biochem (1976) 0.93
On the mechanism of superoxide dismutase. Reaction of the bovine enzyme with hydrogen peroxide and ferrocyanide. Biochim Biophys Acta (1973) 0.93
Cobalt erythrocuprein: preparation and properties. Biochim Biophys Acta (1972) 0.92
The effects of pH and various salts upon the activity of a series of superoxide dismutases. Biochem J (1988) 0.91
Review of 346 patients with free-flap reconstruction following head and neck surgery for neoplasm. J Plast Reconstr Aesthet Surg (2006) 0.90
Magnetic circular dichroism of cobalt-copper and zinc-copper bovine superoxide dismutase. J Biol Chem (1973) 0.90
Oral leukoplakias: to treat or not? Oral Oncol (1997) 0.90
Dependence on freezing of the geometry and redox potential of type 1 and type 2 copper sites of Japanese-lacquer-tree (Rhus vernicifera) laccase. Biochem J (1981) 0.90
The binding of copper ions to copper-free bovine superoxide dismutase. Kinetic aspects. Biochem J (1978) 0.88
Direct bone formation on sand-blasted titanium implants: an experimental study. Biomaterials (1996) 0.87
The involvement of the bridging imidazolate in the catalytic mechanism of action of bovine superoxide dismutase. Biochem J (1977) 0.87
Molecular modeling and electrostatic potential calculations on chemically modified Cu,Zn superoxide dismutases from Bos taurus and shark Prionace glauca: role of Lys134 in electrostatically steering the substrate to the active site. Arch Biochem Biophys (1994) 0.87
Amino acid sequence of chicken Cu, Zn-containing superoxide dismutase and identification of glutathionyl adducts at exposed cysteine residues. Eur J Biochem (1996) 0.86
Purification and properties of bovine caeruloplasmin. Biochem J (1981) 0.86
A novel Co(II) binding site in copper-free superoxide dismutase: evidence for binding of cobalt at the copper binding site. FEBS Lett (1979) 0.86
Ascorbate oxidase. New method of purification of the enzyme from green zucchini squash and identity of its copper moiety with that of cucumber ascorbate oxidase. Ital J Biochem (1974) 0.85
Surfing prognostic factors in head and neck cancer at the millennium. Oral Oncol (1999) 0.85
Surgical planning in reconstruction of mandibular defect with fibula free flap: 15 patients. J Craniofac Surg (2005) 0.84
F19 relaxation as a probe of the oxidation state of Cu, Zn superoxide dismutase. Studies of the enzyme in steady-state turnover. Biochem Biophys Res Commun (1981) 0.84
Reconstitution of ceruloplasmin by the Cu(I)-glutathione complex. Evidence for a role of Mg2+ and ATP. J Biol Chem (1996) 0.84
Evidence for catalytic dismutation of superoxide by cobalt(II) derivatives of bovine superoxide dismutase in aqueous solution as studied by pulse radiolysis. Biochem J (1982) 0.84
Ceruloplasmin impairs endothelium-dependent relaxation of rabbit aorta. Am J Physiol (1997) 0.83
Site-directed mutagenesis of human ceruloplasmin:. production of a proteolytically stable protein and structure-activity relationships of type 1 sites. J Biol Chem (2000) 0.83
Preparation of selectively metal-free and metal-substituted derivatives by reaction of Cu--Zn superoxide dismutase with diethyldithiocarbamate. Biochem J (1981) 0.83
Prognostic value of sentinel node in oral cancer. Tumori (2002) 0.82
A ferrocyanide charge-transfer complex of bovine superoxide dismutase. Relevance of the zinc imidazolate bond to the redox properties of the enzyme. Biochem Biophys Res Commun (1976) 0.82
Isolation and preliminary characterization of electrophoretic variants of copper, zinc superoxide dismutase. Mol Cell Biochem (1982) 0.82
Locoregionally advanced nasopharyngeal carcinoma: induction chemotherapy with cisplatin and 5-fluorouracil followed by radiotherapy and concurrent cisplatin: a phase II study. Oncology (2008) 0.82
An e.p.r. study of the non-equivalence of the copper sites of caeruloplasmin. Biochem J (1986) 0.81
Labile sulfur in human Superoxide dismutase. Eur J Biochem (1975) 0.81
The primary structure of turtle Cu,Zn superoxide dismutase. Structural and functional irrelevance of an insert conferring proteolytic susceptibility. Eur J Biochem (1993) 0.81
Homology modeling of the multicopper oxidase Fet3 gives new insights in the mechanism of iron transport in yeast. Protein Eng (1999) 0.81
Detecting alcohol use disorders in the severely mentally ill. Community Ment Health J (1998) 0.80
Discontinuous vs. in-continuity neck dissection in carcinoma of the oral cavity. Experience of two oncologic hospitals. Acta Otorhinolaryngol Ital (2006) 0.80
Sheep ceruloplasmin: isolation and characterization. Mol Cell Biochem (1983) 0.80
Accessory ultrasonographic findings in chronic liver disease: diameter of splenic and hepatic arteries, fasting gallbladder volume, and course of left portal vein. J Clin Ultrasound (1986) 0.80
ChlVPP/ABVVP, a first line 'hybrid' combination chemotherapy for advanced Hodgkin's lymphoma: a retrospective analysis. Br J Haematol (2004) 0.80
Comparative study of ELISA and indirect immunofluorescence for the detection of anti-neutrophil cytoplasmic antibodies. Evaluation of the SCIMEDX/EURO Diagnostica ELISA assay in a clinical setting. Am J Clin Pathol (1995) 0.80
On the lability and functional significance of the type 1 copper pool in ceruloplasmin. J Biol Inorg Chem (1999) 0.79
Divalent cation binding to ceruloplasmin. Biometals (1996) 0.79
Release of highly active Fet3 from membranes of the yeast Pichia pastoris by limited proteolysis. Arch Biochem Biophys (1999) 0.79
The multidomain structure of ceruloplasmin from calorimetric and limited proteolysis studies. J Biol Chem (1990) 0.79
Presence of reduced type 1 copper in ceruloplasmin as revealed by reaction with hydrogen peroxide. Biochem Int (1984) 0.79
Reversible uncoupling of the copper and cobalt spin systems in cobalt bovine superoxide dismutase at low pH. FEBS Lett (1975) 0.79
High-dose chemotherapy in relapsed or refractory Hodgkin lymphoma patients: a reappraisal of prognostic factors. Hematol Oncol (2012) 0.79
Alteration of peripheral markers of copper homeostasis in Alzheimer's disease patients: implications in aetiology and therapy. J Nutr Health Aging (2007) 0.79
Inhibition of endothelial nitric-oxide synthase by ceruloplasmin. J Biol Chem (1999) 0.79
Surgical treatment of laryngeal carcinoma with subglottis involvement. Oncol Rep (2001) 0.78
Primary structure of a cationic Cu,Zn superoxide dismutase. The sheep enzyme. FEBS Lett (1986) 0.78
Modulation of the redox state of the copper sites of human ceruloplasmin by chloride. J Protein Chem (1995) 0.78
Mandible reconstruction and autogenous frozen bone graft: experimental study on rats. Microsurgery (2001) 0.77
Prognostic factors in head and neck oncology: a critical appraisal for use in clinical practice. Anticancer Res (1999) 0.77
The multifunctional oxidase activity of ceruloplasmin as revealed by anion binding studies. Eur J Biochem (1999) 0.77
Mechanical behavior of quartz fiber reinforced epoxy resins for teeth restoration. Biomed Mater Eng (2006) 0.77
Distribution of copper atoms and binding of carbon monoxide in partially copper-depleted hemocyanin. Biochim Biophys Acta (1984) 0.77
Thyroid disease in northern Italian children born around the time of the Chernobyl nuclear accident. Ann Oncol (2004) 0.76
Tissue microarrays in diffuse large B-cell lymphomas: are they really able to identify distinct prognostic groups in lymphomas of both nodal and extranodal origin? Int J Surg Pathol (2009) 0.76
Structure/function relationships in ceruloplasmin. Adv Exp Med Biol (1999) 0.76
The effect of the presence of the metal prosthetic groups on the subunit structure of bovine superoxide dismutase in sodium dodecyl sulfate. Physiol Chem Phys (1975) 0.76
A complication following tooth extraction: chronic suppurative osteomyelitis. Oral Implantol (Rome) (2013) 0.76
Sentinel node biopsy, lymphatic pattern and selective neck dissection in oral cancer. Oral Dis (2001) 0.76
Primary angiitis of the central nervous system: the penumbra of vasculitis. J Rheumatol (2001) 0.76
Effect of ceruloplasmin on 6-hydroxydopamine oxidation. Biochem Mol Biol Int (1996) 0.76
EPR study of Cu(II) complexes of tridentate amino acids. Arch Biochem Biophys (1971) 0.76
[Calculation of the DMF index in a patient population with terminal uremia undergoing periodic hemodialysis]. Dent Cadmos (1984) 0.75
Overcoming the transclavicular approach: the transmanubrial approach to the thoracic inlet. Head Neck (2000) 0.75
Metastasis to the right stellate ganglion and vagal nerve: pathological alterations causing sudden death. A case report. Acta Otorhinolaryngol Ital (2012) 0.75
An electron paramagnetic resonance study of Aplysia myoglobin. Biochim Biophys Acta (1971) 0.75
[Anatomo-clinical contribution to meningoencephalitis due to "cryptococcus neoformans"]. Arch De Vecchi Anat Patol (1964) 0.75
[Immediate post-extraction implant in infected site. An eight-year clinical and radiographic control]. Minerva Stomatol (2002) 0.75
New therapeutic approaches in head and neck oncology. Can surgeons do more? Tumori (2001) 0.75